a good synopsis. well done!
Medicine is, however littered with logical theories that don't work out in practice. or more often do not offer a statistical advantage.
Even successful drugs poorly marketed fail to achieve commercial success.
so the risks are never small.
My thesis for SPL was built on Vivagel becoming a cash cow to fund the successful commercialisation of the DEP program.
This is broken so I sold out some time ago.
COVID has also impacted the timeframe for successful completion of the DEP platform trials.
I am still cautiously optimistic that SPL can overcome these challenges but am not in a position to be comfortable investing without concrete evidence.
As such will not be re-entering until there is proof of successful trials or deals. I will obviously pay a higher price at that point, but happy to pay for increased certainty.
Best of luck to holders!
a good synopsis. well done!Medicine is, however littered with...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.62M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $18.55K | 139.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 138865 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 86448 | 5 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
13.5¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 13.5¢ | 13.5¢ | 13.0¢ | 6144 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| SPL (ASX) Chart |